• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚烷基胺衍生物在帕金森病实验模型中作为抗氧化剂和神经保护剂的作用

Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.

作者信息

Sanz Elisenda, Romera Manuel, Bellik Lydia, Marco J I, Unzeta Mercedes

机构信息

Departament de Bioquimca i Biologia Molecular, Facultad de Medicina, Institut de Neurociencies, Universitat Autónoma de Barcelona, Campus Universitari de Bellaterra, Barcelona, Spain.

出版信息

Med Sci Monit. 2004 Dec;10(12):BR477-84.

PMID:15567979
Abstract

BACKGROUND

The neuroprotective effect of N-(2-propynyl)2-(5-benzyloxy-indol)methylamine (PF 9601N), a novel MAO B inhibitor, and its metabolite FA 72 on the human neuroblastoma SHSY5Y cell line lesioned with (300 microM) dopamine was assessed and compared with that of 1-deprenyl assayed at identical experimental conditions.

MATERIAL/METHODS: Using this experimental model, PF 961N showed a neuroprotective effect in a dose-dependent manner, and at a concentration of 10 pM a 20% recovery of cell viability was observed. However, the metabolite FA72 assayed under the same experimental conditions showed an increase in cell viability of nearly 50%. In the case of l-deprenyl, a concentration of 100 microM was necessary to recover only 10% of cell viability.

RESULTS

This neuroprotective effect could be explained in terms of the antioxidant capacity of PF 9601N. In this context, the antioxidant capacities of the novel series of MAO inhibitors, PF 9601N and its analogues, were evaluated by their inhibition of the auto-oxidation of dopamine to melanin and by the dichlorofluorescein and 2-deoxyribose methods.

CONCLUSIONS

All of these compounds have the basic structure of an indole ring in common, but show different substituents at different positions in it. The corresponding structure-activity relationship studies allowed us to conclude that the presence of a benzyloxy group, or a hydroxy or methoxy group, at position 5 of the indol ring enhanced these antioxidant characteristics, presenting a decreasing order of antioxidant activity of the primary > secondary > tertiary amines. The antioxidant properties of PF 9601 N would explain its neuroprotective effect observed in SHSY5Y cells lesioned with dopamine.

摘要

背景

评估了新型单胺氧化酶B(MAO B)抑制剂N-(2-丙炔基)-2-(5-苄氧基-吲哚)甲胺(PF 9601N)及其代谢产物FA 72对经(300微摩尔)多巴胺损伤的人神经母细胞瘤SHSY5Y细胞系的神经保护作用,并在相同实验条件下与司来吉兰的作用进行比较。

材料/方法:在该实验模型中,PF 961N呈剂量依赖性地显示出神经保护作用,在浓度为10皮摩尔时观察到细胞活力恢复了20%。然而,在相同实验条件下检测的代谢产物FA72显示细胞活力增加了近50%。对于司来吉兰,需要100微摩尔的浓度才能仅恢复10%的细胞活力。

结果

这种神经保护作用可以用PF 9601N的抗氧化能力来解释。在此背景下,通过抑制多巴胺自氧化为黑色素以及采用二氯荧光素和2-脱氧核糖方法,评估了新型MAO抑制剂系列PF 9601N及其类似物的抗氧化能力。

结论

所有这些化合物都具有共同的吲哚环基本结构,但在其上不同位置显示出不同的取代基。相应的构效关系研究使我们得出结论,吲哚环5位上存在苄氧基、羟基或甲氧基可增强这些抗氧化特性,呈现出伯胺>仲胺>叔胺的抗氧化活性递减顺序。PF 9601 N的抗氧化特性可以解释其在多巴胺损伤的SHSY5Y细胞中观察到的神经保护作用。

相似文献

1
Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.吲哚烷基胺衍生物在帕金森病实验模型中作为抗氧化剂和神经保护剂的作用
Med Sci Monit. 2004 Dec;10(12):BR477-84.
2
Protective effect of N-(2-propynyl)-2-(5-benzyloxyindolyl) methylamine (PF 9601N), a novel MAO-B inhibitor, on dopamine-lesioned PC12 cultured cells.新型单胺氧化酶B抑制剂N-(2-丙炔基)-2-(5-苄氧基吲哚基)甲胺(PF 9601N)对多巴胺损伤的PC12培养细胞的保护作用。
J Pharm Pharmacol. 2003 May;55(5):713-6. doi: 10.1211/002235703765344649.
3
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.R(-)-司来吉兰增强多巴胺对儿茶酚胺能神经母细胞瘤SH-SY5Y细胞的细胞毒性。
Toxicol Appl Pharmacol. 1997 Jan;142(1):186-91. doi: 10.1006/taap.1996.8011.
4
PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.PF 9601N [N-(2-丙炔基)-2-(5-苄氧基-吲哚基)甲胺],一种新型单胺氧化酶B(MAO-B)抑制剂,可减轻1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的C57/BL6小鼠纹状体多巴胺水平的耗竭。
Neurochem Int. 2003 Feb;42(3):221-9. doi: 10.1016/s0197-0186(02)00091-8.
5
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.第二代单胺氧化酶抑制剂雷沙吉兰治疗帕金森病的综合综述。
Clin Ther. 2007 Sep;29(9):1825-49. doi: 10.1016/j.clinthera.2007.09.021.
6
[Molecular mechanisms of the neuroprotective effect of (-)-deprenyl].(-)-司来吉兰神经保护作用的分子机制
Orv Hetil. 2006 Jul 9;147(27):1251-7.
7
Antioxidant properties of PF9601N, a novel MAO-B inhibitor: assessment of its ability to interact with reactive nitrogen species.新型单胺氧化酶B抑制剂PF9601N的抗氧化特性:评估其与活性氮物质相互作用的能力。
Acta Biochim Pol. 2010;57(2):235-9. Epub 2010 Jun 9.
8
Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.单胺氧化酶B抑制对大鼠脑缺血诱导的氧化应激的影响。与合理抗氧化剂的比较。
Arzneimittelforschung. 2008;58(4):160-7. doi: 10.1055/s-0031-1296487.
9
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.雷沙吉兰(TVP - 1012):一种用于帕金森病的新型选择性单胺氧化酶抑制剂。
Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. doi: 10.1016/j.amjopharm.2006.12.001.
10
Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.低纳摩尔浓度的新型亚胺抗氧化剂可保护多巴胺能细胞免受氧化神经毒性。
J Neurochem. 2009 Jul;110(1):118-32. doi: 10.1111/j.1471-4159.2009.06114.x. Epub 2009 May 26.

引用本文的文献

1
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.脑部疾病中的单胺能和组胺能策略与治疗方法
Front Neurosci. 2016 Nov 24;10:541. doi: 10.3389/fnins.2016.00541. eCollection 2016.
2
Neuroprotective effects of the MAO-B inhibitor, PF9601N, in an in vivo model of excitotoxicity.单胺氧化酶-B抑制剂PF9601N在兴奋性毒性体内模型中的神经保护作用。
CNS Neurosci Ther. 2014 Jul;20(7):641-50. doi: 10.1111/cns.12271. Epub 2014 Apr 28.